Cannara Biotech Inc. (TSX:LOVE)
Canada · Delayed Price · Currency is CAD 2.010
+0.070 (3.61%)
Oct 30, 2026, 2:35 PM EDT
Cannara Biotech Market Cap
Cannara Biotech has a market cap or net worth of CAD 198.42 million as of October 30, 2026. It is the 22,989th most valuable company in the world and the 595th biggest in Canada. Its market cap has increased by 25.21% in one year.
Market Cap
198.42M
Enterprise Value
213.61M
Revenue
117.33M
Global Rank
Country Rank
#595 Canada
PE Ratio
18.28
ChartMarket Cap Chart
Since January 14, 2019, Cannara Biotech's market cap has decreased from 211.62M to 198.42M, a decrease of -6.23%. That is a compound annual growth rate of -0.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 198.42M | 20.06% |
| Dec 31, 2025 | 165.28M | 148.11% |
| Dec 31, 2024 | 66.61M | -10.84% |
| Dec 29, 2023 | 74.72M | -10.37% |
| Dec 30, 2022 | 83.36M | -29.55% |
| Dec 31, 2021 | 118.32M | 100.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aurora Cannabis | 371.46M |
| Cipher Pharmaceuticals | 335.73M |
| Cresco Labs | 307.90M |
| TerrAscend | 204.06M |
| BioSyent | 193.27M |
| Organigram Global | 186.83M |
| Cardiol Therapeutics | 181.08M |
| Medexus Pharmaceuticals | 154.93M |